Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MGMT | P16455 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL678301 | 0.87 | ALDH1A1 (0.49) | ALOX15ALDH1A1CYP1B1CES2TSHR | |
| SCHEMBL22922426 | 0.85 | CES2 (0.44) | ALOX15ALDH1A1CYP1B1CES2TSHR | |
| SCHEMBL674829 | 0.84 | ALDH1A1 (0.46) | ALOX15ALDH1A1CYP1B1CES2TSHR | |
| SCHEMBL4785327 | 0.81 | ALOX15 (0.50) | ALOX15ALDH1A1CYP1B1CES2TSHR | |
| SCHEMBL10081724 | 0.81 | ALOX15 (0.59) | ALOX15ALDH1A1CYP1B1CES2TSHR | |
| SCHEMBL17522709 | 0.81 | ALOX15 (0.59) | ALOX15ALDH1A1CYP1B1CES2TSHR | |
| SCHEMBL1302136 | 0.81 | ALOX15 (0.62) | ALOX15ALDH1A1CYP1B1CES2TSHR | |
| SCHEMBL16002382 | 0.81 | ALOX15 (0.62) | ALOX15ALDH1A1CYP1B1CES2TSHR | |
| SCHEMBL22241587 | 0.79 | ALOX15 (0.56) | ALOX15ALDH1A1CYP1B1CES2TSHR | |
| SCHEMBL207377 | 0.78 | ALOX15 (0.59) | ALOX15ALDH1A1CYP1B1CES2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-07-18 | — | — | US | disclosed |
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-07-18 | — | — | US | disclosed |
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-07-18 | — | — | US | disclosed |
| US-20230405125-A1 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | Neonc Technologies, Inc. | 2023-12-21 | — | — | US | disclosed |
| EP-4243794-A1 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | Neonc Technologies, Inc. (US) | 2023-09-20 | — | — | EP | disclosed |
| WO-2022104041-A1 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | Neonc Technologies, Inc. (US) | 2022-05-19 | — | — | WO | disclosed |
| US-20210130271-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NIH - DEITR | 2021-05-06 | — | — | US | disclosed |
| US-20210130271-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NIH - DEITR | 2021-05-06 | — | — | US | disclosed |
| EP-3769754-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | Neonc Technologies, Inc. (US) | 2021-01-27 | — | — | EP | disclosed |
| EP-3769754-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | Neonc Technologies, Inc. (US) | 2021-01-27 | — | — | EP | disclosed |
| US-20130303807-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA | 2013-11-14 | — | — | US | disclosed |
| US-20130303807-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA | 2013-11-14 | — | — | US | disclosed |
| US-20130303807-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA | 2013-11-14 | — | — | US | disclosed |
| US-8507734-B2 | Pharmaceutical compositions comprising monoterpenes | NEONC TECHNOLOGIES INC. (US) | 2013-08-13 | — | — | US | disclosed |
| US-8507734-B2 | Pharmaceutical compositions comprising monoterpenes | NEONC TECHNOLOGIES INC. (US) | 2013-08-13 | — | — | US | disclosed |
| US-8507734-B2 | Pharmaceutical compositions comprising monoterpenes | NEONC TECHNOLOGIES INC. (US) | 2013-08-13 | — | — | US | disclosed |
| US-20110280860-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NEONC TECHNOLOGIES INC. | 2011-11-17 | — | — | US | disclosed |
| US-20110280860-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NEONC TECHNOLOGIES INC. | 2011-11-17 | — | — | US | disclosed |
| US-20110280860-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NEONC TECHNOLOGIES INC. | 2011-11-17 | — | — | US | disclosed |
| WO-2011109635-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NEONC TECHNOLOGIES INC. (US) | 2011-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | ALOX15 35/4885ALDH1A1 793/4885CYP1B1 26/4885 |
| US-20210130271-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | ALOX15 35/4885ALDH1A1 793/4885CYP1B1 26/4885 |
| US-20110280860-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | ALOX15 35/4885ALDH1A1 793/4885CYP1B1 26/4885 |
| US-20230405125-A1 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | IDH3A, IDH1, IDH3B | ALOX15 1329/4885ALDH1A1 162/4885CYP1B1 2195/4885 |
| US-20130303807-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | ALOX15 35/4885ALDH1A1 793/4885CYP1B1 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.